Rather, sequestration of SPT5 by oncogenic levels of MYC decreases Pol II processivity and directionality on genes that are known targets of MYC-dependent repression, for example genes encoding proteins of the TGFβ pathway and regulators of the interactions of tumor cells with the immune system. This evidence concerns the gene MYC and neoplasm.